Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias.
Daniel AlcoleaConstance DelabyLaia MuñozSoraya TorresTeresa EstellésNuole ZhuIsabel BarroetaMaría Carmona-IraguiIgnacio Illán-GalaMiguel Ángel Santos-SantosMiren AltunaIsabel SalaMª Belén Sánchez-SaudinósLaura VidelaSílvia ValldeneuAndrea SubiranaJordi PeguerolesChristophe HirtzJérôme VialaretSylvain LehmannJonathan M SchottNicholas James AshtonKaj BlennowHenrik ZetterbergOlivia BelbinRafael BlesaJordi ClarimónJuan ForteaAlberto LleóPublished in: Journal of neurology, neurosurgery, and psychiatry (2021)
Plasma biomarkers are useful to detect the AT(N) categories, and their use can differentiate patients with pathophysiological evidence of AD. A blood AT(N) signature may facilitate early diagnosis and follow-up of patients with AD through an easy and minimally invasive approach.